Latest news
Paradigm Biopharmaceuticals (ASX:PAR) Gains as Phase 3 Safety Review Clears the Next Gate - KalkineKalkine · Tue, 04 Aug 2026 09:25:00 GMTMTN Nigeria Clears FX Debt, Unlocks New Investment Phase - Punch NewspapersPunch Newspapers · Mon, 03 Aug 2026 01:37:55 GMTAlterity Therapeutics clears FDA Phase 2 hurdle, plans Phase 3 trial for MSA drug ATH434 by end of 2026 - PluangPluang · Thu, 30 Jul 2026 12:02:41 GMTFDA clears registrational Phase II path for Cullinan's CLN-049 in relapsed/refractory AML - AllSciAllSci · Wed, 29 Jul 2026 09:08:33 GMTMannKind’s Inhaled IPF Drug Clears Phase 1b Safety Hurdle, Phase 2 Underway - Yahoo FinanceYahoo Finance · Wed, 29 Jul 2026 07:00:00 GMTInnoCare’s oral TYK2 inhibitor clears phase 3 psoriasis test - Fierce BiotechFierce Biotech · Mon, 27 Jul 2026 14:08:23 GMT